Learning Objectives

  1. Discovery of antigen/antibody systems in primary membranous nephropathy
  2. Pathogenesis of primary membranous nephropathy
  3. The utility of anti-PLA2R in the diagnosis and prognosis of primary membranous nephropathy
  4. Monitoring disease activity using anti-PLA2R
  5. Use of anti-PLA2R in transplantation and recurrent disease
Session date: 
12/04/2019 - 4:00pm to 5:00pm CST
5700 S Maryland Ave
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Dr. Ryyan Hyder